Ketamine for Depression: An MRI Study
Completed · Phase 4
Conditions studied: Depression, Anxious Depression, Major Depressive Disorder
In brief
Ketamine has been shown to decrease symptoms of anxious depression quickly. This decrease has been shown to last for up to one month. MRI technology will be used before and after ketamine for patients with depression to examine the extent to which certain brain areas predict ketamine's antidepressant effects.
Key facts
- Study ID
- NCT02544607
- Run by
- Massachusetts General Hospital
- People needed
- 25
- Starts
- 2016-03-01
- Expected to finish
- 2017-12-29
- Last updated by the study team
- 2019-04-16
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.